Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 3/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 2/20 | 0.43 |
| ▸ | AGXT | P21549 | 2/20 | 0.43 |
| ▸ | ACHE | P22303 | 4/20 | 0.42 |
| ▸ | GSK3A | P49840 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | DAO | P14920 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18669187 | 0.77 | ACHE (0.61) | KDM4ESMN1; SMN2ACHECHRM5AKR1B1 | |
| SCHEMBL26625800 | 0.77 | ACHE (0.61) | KDM4ESMN1; SMN2ACHECHRM5AKR1B1 | |
| SCHEMBL18974330 | 0.75 | CHRM5 (0.61) | ACHECHRM5 | |
| SCHEMBL2733099 | 0.73 | KDM4E (0.49) | KDM4ESMN1; SMN2ACHE | |
| SCHEMBL19555152 | 0.72 | MGLL (0.78) | MGLLFAAHPTGS1PTGS2GSK3A | |
| SCHEMBL17123178 | 0.71 | PTGS1 (0.50) | MGLLFAAHPTGS1PTGS2GSK3A | |
| SCHEMBL20804233 | 0.71 | MGLL (0.42) | SMN1; SMN2MGLLFAAHPTGS1PTGS2 | |
| SCHEMBL28411433 | 0.70 | MGLL (0.60) | SMN1; SMN2MGLLFAAHIDO1GSK3A | |
| SCHEMBL14774793 | 0.70 | KDM4E (0.68) | KDM4ESMN1; SMN2ACHE | |
| SCHEMBL9156397 | 0.69 | KDM4E (0.53) | KDM4ESMN1; SMN2IDO1AGXTACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008124518-A1 | OXO-DIHYDROISOINDOLE SULFONAMIDE COMPOUNDS AS MODULATORS OF THE CCK2 RECEPTOR | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-10-16 | — | — | WO | disclosed |